Mediwhale

Mediwhale is a healthcare tech company that specializes in the field of artificial intelligence (AI) and deep learning. The company's primary focus is on developing AI-based solutions to assist in the diagnosis and treatment of eye diseases. By using AI algorithms, they aim to help doctors identify and treat diseases more accurately and quickly, potentially minimizing the time for disease progression.

Mediwhale's vision is to make healthcare more accessible and efficient through the use of AI. Their flagship product, Dr. Noon, is an AI platform designed to analyze ocular images and predict the risk of eye diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration. In addition to ocular healthcare, Mediwhale also works on integrated solutions, using AI to predict cardiovascular and cerebrovascular diseases from eye images. Their goal is to provide effective tools for early disease prediction and prevention, contributing to the overall improvement of public health.